Literature DB >> 29025021

Misconceptions on the use of MR-Egger regression and the evaluation of the InSIDE assumption.

Jack Bowden1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29025021      PMCID: PMC5837449          DOI: 10.1093/ije/dyx192

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


× No keyword cloud information.
In their letter to this journal, Slob et al. attempt to derive the bias of the MR-Egger regression estimate for a Mendelian randomization (MR) analysis. They show that its bias can be larger than that of the inverse variance weighted (IVW) estimate when the instrument strength independent of direct effect (InSIDE) assumption is violated, and suggest a method for assessing the magnitude of InSIDE violation in any given data set. Slob et al. conclude by cautioning against placing undue reliance on the MR-Egger estimate in practice. Whereas I agree with the basic sentiment of their letter, I wish to make several minor points of correction and clarification. I must also highlight a major flaw in their argument concerning a test for InSIDE violation, so that it is not subsequently repeated by others. I would not recommend the use of MR-Egger regression, in its current form, in the `single sample’ setting, that is when genetic associations with the exposure and with the outcome are measured in the same subjects. This viewpoint is put forward in my reply to a recent letter by Hartwig and Davies to the IJE. Slob et al. helpfully state that the asymptotic bias of the inverse variance weighted (IVW) and MR-Egger estimates (or equivalently their underlying estimands) has in fact already been derived by Bowden et al., specifically in equations (23) and (24). Unfortunately, the expressions given in Slob et al. and referenced to Bowden et al. do not match, and I have some concerns as to their validity. For example, the expression given by Slob et al. for the bias of the IVW estimate depends on the parameter estimate for the instrument-exposure association. This is at odds with the very definition of bias as an expected value of a random variable minus its target parameter. It is hard to ascertain whether the expression for the bias of the MR-Egger estimate is correct, as no derivation is given. However, the denominator of their expression () is confusing because it should surely be a function of the direct effect of the IV on the exposure, represented by , and the indirect effect of the IV on the exposure, represented by . In Bowden et al., we show that the MR-Egger estimate can indeed be more biased than the IVW estimate when InSIDE is violated, especially when the mean pleiotropic effect is close to zero and there is little variation in the single nucleotide polymorphism (SNP) exposure association estimates. For this reason, alternative pleiotropy-robust estimation strategies, such as the weighted median and the mode-based estimate, have been proposed that do not rely on the InSIDE assumption and therefore naturally complement MR-Egger in a sensitivity analysis. Several statistics have also been proposed to evaluate the suitability of MR-Egger regression in two-sample MR studies. The first is the statistic, which quantifies the notion of instrument strength for MR-Egger, and gives an indication of its `weak instrument’ bias. We recommend that should be high (e.g. as close to 1 as possible) for the set of variants in an MR study, in order to be capable of furnishing a reliable MR-Egger causal estimate. Briefly this requires that the SNP exposure association estimates are both precise but sufficiently varied. If it had been correctly stated, it would make the denominator of Slob et al.’s bias expression for MR-Egger large and hence the bias small. A second statistic,, introduced in Bowden et al., quantifies the relative goodness of fit of MR-Egger over the IVW approach. Specifically, it is the ratio of the statistical heterogeneity around the MR-Egger fitted slope, divided by the statistical heterogeneity around the IVW slope. A close to 1 indicates that MR-Egger is not a better fit to the data and therefore offers no benefit over IVW whatsoever, given its relative lack of precision. Conversely, a much less than 1 indicates that MR-Egger is a better fit to the data and its estimate should be taken seriously. We recommend careful and considered use of and to help identify cases where MR-Egger should be used, or indeed avoided. Slob et al. propose to estimate the degree of violation of the InSIDE assumption, by first using the IVW estimate as a proxy for the true causal estimate to calculate individual pleiotropic effects for each variant. I fundamentally disagree with this analysis because it employs circular reasoning: the IVW estimate is generally biased for the causal effect, precisely because of pleiotropy, whenever it has a non-zero mean. To see this, assume for simplicity the following linear model linking single nucleotide polymorphism (SNP) outcome association parameters, , to their corresponding SNP exposure association parameters, , and pleiotropic effect parameters, : Here is the causal effect parameter. Model (1) allows us to see what quantities different estimators (e.g. IVW, MR-Egger) target asymptotically (i.e. their estimands) as the sample size grows large. We will assume that the genetic data have been coded so that the SNP exposure association parameters are positive. Assume also for simplicity, but without loss of generality, that the IVW estimand is a weighted average of ratio estimands , where the weights are equal to (as would be the case if the SNPs had identical allele frequency), that is: The second term on the right hand side of equation (2) represents the asymptotic bias of the IVW estimate. Consider the numerator of this bias term. It is zero whenever the sample covariance of and , say, and the product of their means, say, is zero. That is, if: Therefore, formula (3) makes clear that is only equal to in general when (i) the InSIDE assumption holds perfectly (so is zero) and (ii) the mean pleiotropic effect is zero (we have already ruled out the possibility that is zero). Of course, both (i) and (ii) may be false and equation (3) still equal zero in the case where one perfectly cancels out the other. When Slob et al. attempt to estimate the pleiotropy parameters by plugging the IVW estimate given in formula (2) into equation (1), and then look to see if they are correlated with the SNP exposure associations, they are instead evaluating the correlation between and However, these quantities are clearly correlated whenever equation (3) is non-zero. For example, when the InSIDE assumption is satisfied but happens to be non-zero. The correlations calculated by Slob et al. in their two examples were both negative. Formula (3) and formula (4) imply that the mean pleiotropic effect must have been positive in each case. In contrast to the IVW estimate, MR-Egger regression only relies on the InSIDE assumption and not additionally on non-zero mean pleiotropy. Indeed, it exploits InSIDE to identify, estimate and adjust for non-zero mean pleiotropy. Slob et al. note that the correlation between their estimated pleiotropic effects and instrument strength is reduced when using the MR-Egger estimate as opposed to the IVW estimate in place of the causal effect. It is easy to show that it should be identical to zero. That it is not zero in their examples is probably a reflection of the fact that they have estimated the MR-Egger regression coefficients via a weighted analysis (e.g. by accounting for differing allele frequencies), but evaluated the correlation in an unweighted fashion. The letter by Slob et al. re-states some facts already in the public domain, but unfortunately it contains several minor inaccuracies and one serious, unhelpful misconception. I would strongly discourage researchers from using the IVW estimate to quantify the magnitude of InSIDE violation and to assess the relative bias of the IVW and MR-Egger estimates, because the IVW estimate also requires the InSIDE assumption. This is explained in Bowden et al. If a reliable test for violation of the InSIDE assumption could be developed, it would be extremely useful for determining the reliability of the IVW and MR-Egger estimates, and would be of great importance to the field of Mendelian randomization. Unfortunately, the method proposed by Slob et al. is flawed. Other authors have also recently developed informal strategies for testing InSIDE that have been shown to be unreliable. In my opinion, external data of some sort are required to test the InSIDE assumption. Multivariable Mendelian randomization methods, and future extensions thereof, are a promising avenue of research in this regard.
  11 in total

1.  Why internal weights should be avoided (not only) in MR-Egger regression.

Authors:  Fernando Pires Hartwig; Neil Martin Davies
Journal:  Int J Epidemiol       Date:  2016-09-20       Impact factor: 7.196

2.  A note on the use of Egger regression in Mendelian randomization studies.

Authors:  Eric A W Slob; Patrick J F Groenen; A Roy Thurik; Cornelius A Rietveld
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

3.  Difficulties in Testing the Instrument Strength Independent of Direct Effect Assumption in Mendelian Randomization.

Authors:  Jack Bowden; Stephen Burgess; George Davey Smith
Journal:  JAMA Cardiol       Date:  2017-08-01       Impact factor: 14.676

4.  Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.

Authors:  Jon White; Daniel I Swerdlow; David Preiss; Zammy Fairhurst-Hunter; Brendan J Keating; Folkert W Asselbergs; Naveed Sattar; Steve E Humphries; Aroon D Hingorani; Michael V Holmes
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

5.  Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.

Authors:  Stephen Burgess; Simon G Thompson
Journal:  Am J Epidemiol       Date:  2015-01-27       Impact factor: 4.897

6.  Response to Hartwig and Davies.

Authors:  Jack Bowden; Stephen Burgess; George Davey Smith
Journal:  Int J Epidemiol       Date:  2016-09-20       Impact factor: 7.196

7.  Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.

Authors:  Fernando Pires Hartwig; George Davey Smith; Jack Bowden
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

8.  A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.

Authors:  Jack Bowden; Fabiola Del Greco M; Cosetta Minelli; George Davey Smith; Nuala Sheehan; John Thompson
Journal:  Stat Med       Date:  2017-01-23       Impact factor: 2.373

9.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.

Authors:  Jack Bowden; George Davey Smith; Philip C Haycock; Stephen Burgess
Journal:  Genet Epidemiol       Date:  2016-04-07       Impact factor: 2.135

10.  Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.

Authors:  Jack Bowden; Fabiola Del Greco M; Cosetta Minelli; George Davey Smith; Nuala A Sheehan; John R Thompson
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

View more
  11 in total

1.  Insulin Receptor Genetic Variants Causal Association with Type 2 Diabetes: A Mendelian Randomization Study.

Authors:  Ghada A Soliman; C Mary Schooling
Journal:  Curr Dev Nutr       Date:  2022-03-29

2.  Causal Effects of Overall and Abdominal Obesity on Insulin Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization Study.

Authors:  Hua Xu; Chuandi Jin; Qingbo Guan
Journal:  Front Genet       Date:  2020-07-02       Impact factor: 4.599

3.  Genetic determinants of daytime napping and effects on cardiometabolic health.

Authors:  Hassan S Dashti; Iyas Daghlas; Jacqueline M Lane; Yunru Huang; Miriam S Udler; Heming Wang; Hanna M Ollila; Samuel E Jones; Jaegil Kim; Andrew R Wood; Michael N Weedon; Stella Aslibekyan; Marta Garaulet; Richa Saxena
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

4.  Fine-mapping and cell-specific enrichment at corneal resistance factor loci prioritize candidate causal regulatory variants.

Authors:  Xinyi Jiang; Nefeli Dellepiane; Erola Pairo-Castineira; Thibaud Boutin; Yatendra Kumar; Wendy A Bickmore; Veronique Vitart
Journal:  Commun Biol       Date:  2020-12-11

5.  Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model.

Authors:  Zhaotong Lin; Yangqing Deng; Wei Pan
Journal:  PLoS Genet       Date:  2021-11-18       Impact factor: 5.917

Review 6.  Mendelian Randomization: A Review of Methods for the Prevention, Assessment, and Discussion of Pleiotropy in Studies Using the Fat Mass and Obesity-Associated Gene as an Instrument for Adiposity.

Authors:  Fiston Ikwa Ndol Mbutiwi; Tatiana Dessy; Marie-Pierre Sylvestre
Journal:  Front Genet       Date:  2022-02-04       Impact factor: 4.599

7.  A practical problem with Egger regression in Mendelian randomization.

Authors:  Zhaotong Lin; Isaac Pan; Wei Pan
Journal:  PLoS Genet       Date:  2022-05-04       Impact factor: 6.020

8.  Role of an unclassified Lachnospiraceae in the pathogenesis of type 2 diabetes: a longitudinal study of the urine microbiome and metabolites.

Authors:  Kangjin Kim; Sanghun Lee; Sang-Chul Park; Nam-Eun Kim; Chol Shin; Seung Ku Lee; Youngae Jung; Dankyu Yoon; Hyeonjeong Kim; Sanghyun Kim; Geum-Sook Hwang; Sungho Won
Journal:  Exp Mol Med       Date:  2022-08-05       Impact factor: 12.153

9.  Causal association of body mass index with hypertension using a Mendelian randomization design.

Authors:  Mee-Ri Lee; Youn-Hee Lim; Yun-Chul Hong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Genome-wide Association Study of Estradiol Levels and the Causal Effect of Estradiol on Bone Mineral Density.

Authors:  Daniel Schmitz; Weronica E Ek; Elin Berggren; Julia Höglund; Torgny Karlsson; Åsa Johansson
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.